Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL.
|
Columbia University / Teresa Palomero, PhD |
Young Investigator Grants |
2007 |
New York |
PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia |
Massachusetts General Hospital / Jessica Blackburn, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors
|
Children’s National Medical Center / Suzanne Miles |
Young Investigator Grants |
2009 |
District of Columbia |
Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy |
Fred Hutchinson Cancer Research Center / Colin Godwin, MD |
Young Investigator Grants |
2018 |
Washington |
Promoter Hypermethylation in MLL-Rearranged Leukemias: Biology and Therapeutic Targeting |
The Johns Hopkins University School of Medicine / Eric Schafer |
Young Investigator Grants |
2010 |
Maryland |
Single-cell RNA-seq Profiling of Transcriptional Transition States During Human Retinoblastoma |
Children’s Hospital Los Angeles / Sunhye Lee, PhD |
Young Investigator Grants |
2016 |
California |
Beyond Febrile Neutropenia: Risks Associated with Antibiotic Choice in Children with Leukemia that Undergo Transplant |
Children’s Hospital of Philadelphia / Caitlin Elgarten, MD |
Young Investigator Grants |
2018 |
Pennsylvania |
The Impact of Hypoxia on Epigenetic Changes in Neuroblastoma |
University of Chicago / Sakshi Uppal, PhD |
Young Investigator Grants |
2017 |
Illinois |
The Role of Germline Variants in Infant Leukemogenesis |
Washington University / Margaret Ferris, MD/PhD |
Young Investigator Grants |
2019 |
Missouri |
Identification of Novel Treatment Targets by Exploring the Interaction of Rhabdomyosarcoma-Associated Oncogenes with Cellular Context in a Mouse Model of Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Simone Hettmer |
Young Investigator Grants |
2010 |
Massachusetts |